by Talking Medicines | Feb 13, 2023
Enterprise investment in technology is aligned to increasing efficiency and decreasing costs. In a tough economy ROI is even more scrutinised. Is social listening a nice to have or must have? Is it a part of the technology lift that can help drive ROI? Natural...
by Talking Medicines | Dec 22, 2022
We are excited to share with you our top 5 most popular blogs of 2022, all of which cover a wide range of topics within the life sciences industry. From pharma marketing to women’s health to black box warnings, these articles offer valuable information and...
by Talking Medicines | Jun 22, 2022
Global Business Report (GBR) have recently published “United States Life Sciences 2022” Report. It was published in partnership with BioNJ, Biocom California and CPHI. Jo Halliday ,CEO was asked to contribute to the report on the transformational...
by Talking Medicines | May 18, 2022
Last week (9-15 May) was Mental Health Awareness Week, and was founded 21 years ago by The Mental Health Foundation. The theme for this year is ‘loneliness’. The Mental Health Foundation says: “One in four adults feel lonely some or all of the time. There’s no single...
by Talking Medicines | Apr 7, 2022
The post-Covid world is unpredictable; there is little that hasn’t been touched by the pandemic. Whilst the “new normal” has many remnants of our old lives, there is a sense of unpredictability and vulnerability that we didn’t have to face...
by Talking Medicines | Feb 2, 2022
Talking Medicines, the world’s first Artificial Intelligence (AI) driven patient intelligence company designed to meet the needs of Pharma, has closed a £1.5 million funding round to support its ambitions plans for expansion into the US. Boston based life science...
